and extended-release metformin (Met XR) in otherwise healthy volunteers. Study 2 assessed glycemic control in subjects with type 2 diabetes (T2DM) over 12 weeks. Research Design and Methods Study ...

In addition, it provides Glucophage XR, a metformin hydrochloride extended-release tablet that treats type 2 diabetes; Seroquel XR, a quetiapine fumarate extended-release tablet for the treatment ...

A new report suggests that Samsung will launch its hotly anticipated XR glasses in Q3 2025. The device will reportedly feature a Qualcomm AR1 chipset, a 12MP camera, and a 155mAh battery.

Dapagliflozin, sold under the brand names Farxiga (US) and Forxiga (EU) among others, is a medication used to treat type 2 diabetes. It is also used to ...

You’ve reached your account maximum for followed topics. A new report suggests that Samsung's AI-powered XR smart glasses will launch by the third quarter of next year. The smart glasses will ...

Image Source : FILE IMAGE Know whether metformin is good for weight loss or not. Metformin is a drug very commonly used for diabetes mellitus (DM) for a quite long period. It is available in many ...

iOS 12, up to iOS 17.6.1 ...

Samsung has confirmed it will release an XR device in 2025. The confirmation comes from its third quarter earnings report where a slide mentioned XR devices under 2025 Outlook. There's been some ...

The two drugs are metformin, one of the most widely used diabetes medications, and the GLP-1 class of medications that include Ozempic, Mounjaro and Saxenda. Advertisement A study of nearly 13,000 ...

The app’s been adding text and image resources allowing it to identify “XR headset” devices. With both Samsung and Google interested in XR hardware, it would make sense to plan like this for ...

It seems like everything is coming together for the future of immersive experiences based on Android XR. Google and Samsung have been working for a long time on both the hardware and software that ...

A study of nearly 13,000 people with diabetes and asthma found that metformin cut a patient's odds for asthma attacks by 30%, while adding in a GLP-1 med reduced it by another 40%. The effects ...